As Pfizer INC (PFE) Stock Declined, Shareholder Jpmorgan Chase & Company Increased Its Stake

April 22, 2018 - By Marie Mckinney

Pfizer Inc. (NYSE:PFE) LogoInvestors sentiment increased to 1.06 in 2017 Q4. Its up 0.10, from 0.96 in 2017Q3. It improved, as 51 investors sold PFE shares while 675 reduced holdings. 134 funds opened positions while 632 raised stakes. 4.07 billion shares or 0.28% more from 4.06 billion shares in 2017Q3 were reported. Field And Main Natl Bank invested in 6,165 shares or 0.21% of the stock. Registered Inv Advisor has 1.05% invested in Pfizer Inc. (NYSE:PFE) for 60,776 shares. Kingfisher Cap Ltd Com invested in 0.9% or 39,094 shares. Armstrong Henry H, Pennsylvania-based fund reported 9,698 shares. Warren Averett Asset Management Limited Liability Corporation holds 0.19% of its portfolio in Pfizer Inc. (NYSE:PFE) for 36,386 shares. Chickasaw Capital Mgmt, a Tennessee-based fund reported 6,675 shares. Pacific Global Investment Management holds 0.48% or 61,319 shares in its portfolio. Headinvest Ltd Co accumulated 30,281 shares. Legacy Private Trust reported 61,440 shares stake. New York-based Amalgamated Bancshares has invested 0.73% in Pfizer Inc. (NYSE:PFE). Gfs Advsrs Lc reported 62,869 shares. Greatmark Investment Prtn reported 5,638 shares stake. Cohen Cap Mgmt owns 69,506 shares for 0.59% of their portfolio. Ngam Limited Partnership stated it has 1.46 million shares. Comerica, Michigan-based fund reported 108,681 shares.

Since December 15, 2017, it had 0 insider buys, and 12 insider sales for $12.99 million activity. SUSMAN SALLY sold 33,368 shares worth $1.24M. 42,393 shares valued at $1.52 million were sold by HILL CHARLES H on Tuesday, March 6. $64,679 worth of Pfizer Inc. (NYSE:PFE) was sold by CORNWELL W DON. LANKLER DOUGLAS M sold 50,000 shares worth $1.84M. $2.55M worth of Pfizer Inc. (NYSE:PFE) was sold by Dolsten Mikael. The insider LUND-JURGENSEN KIRSTEN sold 9,510 shares worth $353,677.

Jpmorgan Chase & Company increased its stake in Pfizer Inc (PFE) by 1.29% based on its latest 2017Q4 regulatory filing with the SEC. Jpmorgan Chase & Company bought 1.47M shares as the company’s stock declined 3.13% with the market. The institutional investor held 115.58M shares of the health care company at the end of 2017Q4, valued at $4.19B, up from 114.11M at the end of the previous reported quarter. Jpmorgan Chase & Company who had been investing in Pfizer Inc for a number of months, seems to be bullish on the $217.90 billion market cap company. The stock increased 0.27% or $0.1 during the last trading session, reaching $36.63. About 21.23 million shares traded. Pfizer Inc. (NYSE:PFE) has risen 2.43% since April 22, 2017 and is uptrending. It has underperformed by 9.12% the S&P500.

Jpmorgan Chase & Company, which manages about $474.64B US Long portfolio, decreased its stake in Bb&T Corp (NYSE:BBT) by 1.72 million shares to 9.70 million shares, valued at $482.13M in 2017Q4, according to the filing. It also reduced its holding in Jp Morgan Exchange Traded Fd by 227,037 shares in the quarter, leaving it with 294,099 shares, and cut its stake in Noble Corp Plc (NYSE:NE).

Pfizer Inc. (NYSE:PFE) Ratings Coverage

Among 11 analysts covering Pfizer (NYSE:PFE), 5 have Buy rating, 1 Sell and 5 Hold. Therefore 45% are positive. Pfizer had 16 analyst reports since October 26, 2017 according to SRatingsIntel. The firm has “Hold” rating by Jefferies given on Thursday, October 26. The rating was maintained by UBS on Wednesday, November 1 with “Buy”. The stock of Pfizer Inc. (NYSE:PFE) has “Buy” rating given on Tuesday, November 21 by BMO Capital Markets. The firm earned “Neutral” rating on Wednesday, January 31 by Credit Suisse. SunTrust maintained it with “Hold” rating and $40.0 target in Sunday, January 28 report. Barclays Capital downgraded Pfizer Inc. (NYSE:PFE) on Thursday, April 5 to “Equal-Weight” rating. The company was maintained on Friday, December 15 by BMO Capital Markets. The stock of Pfizer Inc. (NYSE:PFE) has “Hold” rating given on Tuesday, January 16 by Jefferies. The stock of Pfizer Inc. (NYSE:PFE) has “Hold” rating given on Friday, April 13 by Jefferies. Piper Jaffray maintained Pfizer Inc. (NYSE:PFE) rating on Tuesday, October 31. Piper Jaffray has “Buy” rating and $54.0 target.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: